Skip to main content

Table 3 Comparisons of clinical parameters between dialysis modalities

From: Residual renal function in chronic dialysis is not associated with reduced erythropoietin-stimulating agent dose requirements: a cross-sectional study

Parameter

Haemodialysis

Peritoneal dialysis

P-value

Number of patients

67

33

Residual renal function, n (%)

 Present

15

(22.4)

21

(63.6)

<0.01

 Absent

52

(77.6)

12

(36.4)

Dialysis vintage (months)

70

(41–125)

14.5

(10–47)

<0.01

Haemoglobin (g/dL)

10.1

(9.3–11)

9.5

(7.9–10.8)

0.05

ESA dose per week (IU)

6000

(6000–10,000)

6000

(6000–6000)

0.16

ERI

10.79

(5.93–16.02)

10.20

(8.06–14.25)

0.84

  1. Values expressed in a range in parentheses refer to interquartile ranges; single values refer to percentage of the total population. ESA erythropoietin-stimulating agent; ERI erythropoietin resistance index